Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Study finds drugs stop HIV transmission, polio endgame strategy includes new technologies and vaccines, and FDA approves first ever vaccine for dengue fever

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

CDC
Research Roundup: clinical trials for experimental Ebola vaccines, genetic traits that affect malaria risk, and progress toward a hookworm vaccine

The National Institute of Allergy and Infectious Diseases (NIAID) announced last week that two experimental Ebola vaccines appear to be safe for widespread use, based on early results of clinical trials in Liberia.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: new discoveries in the search for a malaria vaccine and tuberculosis treatment and lessons from the Ebola epidemic

A team of scientists at Heinrich-Heine Universität Düsseldorf have identified a potential new player in the fight against tuberculosis (TB).

GHTC
Read More
US Centers for Disease Control and Prevention
Fighting for the future: Why we must come together to fight antibiotic resistance around the globe

I am pleased to have the opportunity to write about what is perhaps today’s most vexing public health challenge—the growing threat of antibiotic resistance.

Read More
PATH/Gabe Bienczycki
Research Roundup: discoveries in malaria research, remaining barriers to the development of an Ebola vaccine, and a diagnostic for maternal survival

Scientists at Karolinska Institutet in Sweden have identified the protein that explains why people with blood type O are protected from coma and death resulting from severe cases of malaria.

GHTC
Read More
PATH/Lesley Reed
Research Roundup: Leadership shifts at USAID, new discoveries in tuberculosis research, an emerging model for nonprofit pharmaceutical companies, and more

The US Agency for International Development (USAID) announced last week that Ariel Pabos-Mendez, the assistant administrator for Global Health, will serve as the coordinator for Child and Maternal Survival.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: Progress towards a vaccine for HIV, a rapid diagnostic and experimental drug for Ebola, and congressional support for global health research

A new compound has successfully protected monkeys from HIV, according to a study published in Nature last week.

GHTC
Read More
PATH/Heng Chivoan
Research Roundup: A new drug for tuberculosis, contraceptive research and development, drug-resistant malaria, and more

The TB Alliance, a member of the Global Health Technologies Coalition, announced last week that it will be starting Phase 1 clinical trials for a new tuberculosis (TB) drug candidate.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: A promising malaria vaccine, a virulent new form of HIV, climate change, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
DNDi/João Roberto Ripper
Chagas disease: A silent kiss and a neglected killer

Valentine’s Day seems like a fitting occasion to shine some needed light on a disease that can begin with a late-night “kiss” but ends with a broken heart.

Read More
PATH/Wendy Stone
Research Roundup: FDA Commissioner to step down, a Grand Challenge for neglected diseases, funding for reproductive health research and development, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
WHO Executive Board agrees on set-up of pooled fund for global health R&D

In this guest post, Alexandra Heumber—head of policy affairs at the Drugs for Neglected Diseases initiative—discusses actions taken during the World Health Organization (WHO)’s Executive Board meeting which could impact financing for the research and development (R&D) of new health technologies for developing countries.

Read More
Obama Administration’s FY2016 budget presents mixed outlook for global health R&D

On Monday the White House turned heads by releasing, for the first time since 2010, an on-time budget. Overall the White House presented a mixed outlook for global health research and development (R&D).

GHTC
Read More
The state of reproductive health R&D for developing countries

In this guest post, Dale Halliday—an analyst at Policy Cures—discusses the finding of Policy Cures’ report on funding for reproductive health technology research and development (R&D) in developing countries.

Policy Cures
Read More
PATH/Mike Wang
Research Roundup: The 21st Century Cures Act, US funding for antimicrobial resistance, vaccine development and funding, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: Ebola vaccine trials in Liberia, the spread of insect-borne tropical diseases, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Obama highlights global health and innovation in State of the Union address

While others were playing State of the Union bingo or creating pretty word clouds, GHTC was closely watching the State of the Union address to see what President Barack Obama would say about US engagement in global health and America’s leadership in science and innovation.

Read More
PATH/Will Boase
Research Roundup: Clinical trial data sharing, vaccines to look forward to, and public-private partnerships for global health research and development

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: MenAfriVac® prequalification, an innovative new antibiotic, Ebola vaccine trials, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
10 reasons why the US policymakers should support global health research and development

At the Global Health Technologies Coalition, our mission is to advance—through advocacy—the research and development (R&D) of new tools to prevent, diagnose, and treat global diseases.

Read More
PATH/Evelyn Hockstein
Research Roundup: Experimental Ebola vaccines and treatments, HIV prevention research, and an 18-year high in drug approvals

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More